Jie Huang - Guangdong Lung Cancer Institute, Southern Medical University

基本信息

Career Trajectory

Bio

Jie Huang received the Ph.D. degree in oncology from Southern Medical University, Guangzhou, China, in 2016. She joined the Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital, Guangzhou, as a Clinical Doctor in 2016. She is involved in several national research projects as a Principle Investigator or participant. Her research interests include immunotherapy, target therapy, and their resistance mechanisms in lung cancer.

Research Interests

Papers共 41 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

LncRNA EGFR‑AS1 Promotes Lung Cancer Cell Proliferation, Invasion and Metastasis Via Regulation of Mir‑449a/hdac1

Jie Huang, Baoqing Wang, Qin Wu,Liming Wang, Chao Guan

EXPERIMENTAL AND THERAPEUTIC MEDICINEno. 2 (2025)

Cited0Views0WOSBibtex

First-Line Camrelizumab Versus Placebo Plus Chemotherapy with or Without Radiotherapy for Brain Metastases in Non-Small-Cell Lung Cancer: the CTONG 2003 Randomized Placebo-Controlled Trial

Yang-Si Li,Qitao Yu,Qing Bu,Lizhu Lin,Fangling Ning,Yun Zhao,Gang Wu,Gen Lin,Aimin Zang, Hao Sun,Jie Huang,Hai-Yan Tu,Shenglin Ma,Chengzhi Zhou,Anwen Liu, Cailian Wang,Yu Yao,Guang Han,Jun Zhao,Qing Zhou

Journal of Thoracic Oncology (2025)

Cited0Views0WOSBibtex

Phase Separation of RXRγ Drives Tumor Chemoresistance and Represents a Therapeutic Target for Small-Cell Lung Cancer

Hong Wang,Jie Huang, Zhenhua Zhang, Yana An, Huizi Sun, Jianghe Chen,Weineng Feng,Hao Duan,Yonggao Mou,Yuanxiang Wang,Peiqing Liu, Huihao Zhou,Hong-Wu Chen,Jian Zhang,Xiaoyun Lu,Junjian Wang

Proceedings of the National Academy of Sciences of the United States of America（2025）

Cited0Views0WOSBibtex

Neoadjuvant Aumolertinib for Unresectable Stage III EGFR-mutant Non-Small Cell Lung Cancer: a Single-Arm Phase II Trial

Dongliang Bian, Shuyu Ji, Yue Liu, Zhida Huang,Lei Jiang,Ming Liu,Xiao Bao,Jie Yang, Yirui Zhou, Junjie Hu, Liangdong Sun, Yingzhi Zheng,Jie Huang, Jing Liu,Xinsheng Zhu,Jing Zhang,Lele Zhang,Xiaogang Liu,Wenxin He,Dong Xie,Yuming Zhu,Chunyan Wu,Deping Zhao,Liang Duan,Gening Jiang,Peng Zhang

Nature communicationsno. 1 (2025): 3143-3143

Cited0Views0WOSNATUREBibtex

Osimertinib As Salvage Therapy in Advanced Non-Small Cell Lung Cancer after Aumolertinib Resistance with T790M Mutation: A Case Report

Yongtong Tang,Jilan Xu,Qingle Chen,Jianping Lu, Li Ren, Taihe Lan, Taihua Liao,Xiaoling Chen, Hui Yi,Jun Zhang,Jie Huang

Clinical case reportsno. 2 (2025): e70219-e70219

Cited0Views0WOSBibtex

Exploring YAP1-related TIME in SCLC: Implications for Survival and Treatment Response to Immuno-Chemotherapy

Yu-Qing Chen,Jia-Xiong Tan, Ling-Ling Gao, Jia-Xing Yang,Jie Huang,Jin-Ji Yang,Qiang Zhao

Cancer drug resistance (Alhambra, Calif)（2025）

Cited0Views0WOSBibtex

Mixed Response to the First‐line Treatment of KRAS G12C Inhibitor, Sotorasib, in Non‐small Cell Lung Cancer: A Brief Report

Jiao Yang,Jie Huang, Gongjun Yuan,Xiao-Cheng Lin,Hua-Jun Chen,Jin-Ji Yang

CLINICAL CASE REPORTSno. 6 (2024)

Cited0Views0WOSBibtex

Therapeutic Targeting ERRγ Suppresses Metastasis Via Extracellular Matrix Remodeling in Small Cell Lung Cancer

Hong Wang,Huizi Sun,Jie Huang,Zhenhua Zhang,Guodi Cai,Chaofan Wang,Kai Xiao,Xiaofeng Xiong,Jian Zhang,Peiqing Liu,Xiaoyun Lu,Weineng Feng,Junjian Wang

EMBO MOLECULAR MEDICINEno. 9 (2024): 2043-2059

Cited0Views0WOSBibtex

Genotyping of RB1 Status Identifies Two Distinct Subtypes in EGFR-mutant Lung Cancers with SCLC Transformation

J. Huang,C. Zhang,S-L Zhang,W. Huang,J-J Yang,Y-L Wu

JOURNAL OF THORACIC ONCOLOGY（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn